News and Comments

REGENERON: A GREAT LESSON TO LEARN

  Thursday, May 05, 2011

First, we congratulate our subscribers who did not follow the skeptics and believed in the rationality of science and kept their Vertex’ (VRTX) and Regeneron’s (REGN) shares despite years of negative campaigns against the two firms. Following the rally in VRTX, another rally started in REGN for rational reasons. Both firms are among our TOP TEN selection. More...


Recent Postings


Archive


Tags

Anacor (ANAC) Seattle Genetics (SGEN) C4 Therapeutics Sequenom (SQNM) KERYX (KERX) Benlysta (belimumab) Endometrial Cancer Ariad (ARIA) Telaprevir Tysabri ARCA (ABIO) Mirati Therapeutics (MRTX) Abbott Laboratories (ABT) SUNESIS PHARMACEUTICALS (SNSS) Array Pharmaceuticals (ARRY) Sanofi (SNY) Sangamo (SGMO) Roche (RHHBY) Onyx (ONXX) Amgen (AMGN) Sanofi (SNA) Pluristem (PSTI) Cytokinetics (CYTK) Vertex (VRTX) NEKTAR (NKTR)) Jazz Pharmaceuticals (JAZZ) Alnylam (ALNY) Intermune (ITMN) Velcade (bortezomib) GUARDIAN HEALTH KITE (KITE) Intrexon (XON) Incyte (INCY) Regeneron (REGN) Elan (ELN) Ridaforolimus OSI (OSIP) Xoma (XOMA) ABBVIE (ABBV) Aimmune Therapeutics (AIMT) Genentech Roche (ROCHE) Herceptin Inovio (INO) CompuGen (CGEN) SERES THERAPEUTICS (MCRB) Gilead (GILD) Revlimid (lenolidamide) ImmunoGen (IMGN) NANTKWEST (NK) Human Genome Sciences (HGSI) Zerenex ZALTRAP™ Trastuzumab-DM1 IDERA (IDRA) Merck (MRK) BIOMARIN (BMRN) Dynavax (DVAX) HALOZYME (HALO) Prolor Biotech (PBTH) ADVENTRIX (ANX) Idenix (IDIX) Theravance (THRX) Intercept (ICPT) Bristol-Myers Squibb (BMY) Sarepta (SRPT) Exelixis (EXEL) TOKAI (TKAOI) ISIS (ISIS) SYNTA (SNTA) Micromet (MITI) Galena (GALE) Agenus (AGEN Agenus (AGEN) Prosensa (RNA) Ziofpharm (ZIOP) galapagos (GLPG) Sanofi-Aventis (SAN) Anadys (ANDS) Valeant Pharmaceuticals International (VRX) Auspex (ASPX) Biogen Idec (BIIB) JUNO (JUNO) GlaxoSmithKline (GSK) VANDA (VNDA) Illumina (ILMN) Dendreon (DNDN) Rapamune AERIE PHARMACEUTICALS Multiple Myeloma Biocryst (BCRX)